Skip to content

Aortic Dissection With 4-dimensional Phase-contrast Magnetic Resonance Imaging

Aortic Dissection With 4-dimensional Phase-contrast Magnetic Resonance Imaging

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04481542
Enrollment
50
Registered
2020-07-22
Start date
2018-03-01
Completion date
2025-12-12
Last updated
2020-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRI

Keywords

CVS MRI

Brief summary

We prospectively collected information on consecutive patients who had been evaluated using 4D PC-MRI for aortic pathology in a tertiary hospital between April 2018 and Feb 2020. Patients were eligible for inclusion in the study if they had a clinical indication for CTA of aortic dissections.

Detailed description

The exclusion criteria were non-MRI-compatible ferromagnetic devices and pregnancy. In addition, patients with poor compliance and with unstable status that prevented them from lying down for the MRI protocol were excluded. Initially, 26 patients evaluated. One patient was excluded due to fever at the scheduled time, and another was unable to lie down due to complicated spine disease. All patients underwent CTA scan on a 64-slice multidetector scanner (Somatom Sensation 64; Siemens Healthcare, Erlangen, Germany) with the intravenous administration of contrast media, followed by 4D PC-MRI to assess aortic pathology

Interventions

DIAGNOSTIC_TESTMRI

check MRI quality in aorta

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Patients were eligible for inclusion in the study if they had a clinical indication for CTA of aortic dissections. The

Exclusion criteria

were non-MRI-compatible ferromagnetic devices and pregnancy. In addition, patients with poor compliance and with unstable status that prevented them from lying down for the MRI protocol were excluded.

Design outcomes

Primary

MeasureTime frameDescription
stroke volume5 yearsanatomic/hemodynamic parameter

Secondary

MeasureTime frameDescription
adverse event5 yearsdiagnostic function

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026